Oklahoma State University Medical Trust

Oklahoma State University Medical Trust was paid $20.00M by Medicaid between Jan 2018 and Nov 2024, across 66 billing codes. Its largest line is 99283, emergency room visit (moderate) — 43% of everything it billed.

33Billing provider infoOKLAHOMA STATE UNIVERSITY MEDICAL TRUST
TULSA, OK 74127

33aNPI1578704938assigned 03/16/2009

33bProvider typeGeneral Acute Care Hospital

28Total paid$20.00M

24GClaims159,872

24DCodes billed66

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other General Acute Care Hospital providers in Oklahoma

Rank by total paid#6 of 75

Median peer was paid$3.66M

This provider vs. median5.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	17,232	$2.16M
2019	15,257	$2.22M
2020	9,681	$1.53M
2021	19,363	$2.47M
2022	36,456	$4.14M
2023	42,698	$4.96M
2024incomplete	19,185	$2.54M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	43%	51,319	50,790	$8.58M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	31%	24,543	24,374	$6.23M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	16%	9,779	9,611	$3.19M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.0%	2,977	2,947	$407K
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.3%	2,656	2,647	$265K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	1.2%	1,854	1,848	$250K
99281	Emergency department visit for the evaluation and management, self-limited or minor	1.0%	3,502	3,481	$205K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	2,789	2,650	$172K
71045	Radiologic examination, chest; single view	<1%	9,699	9,574	$141K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	543	361	$79K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	8,718	8,306	$50K
85027		<1%	8,444	8,138	$48K

54 more codes

81025		<1%	6,177	$46K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	929	$45K
96375	Therapeutic injection; each additional sequential IV push	<1%	671	$28K
81001		<1%	5,204	$28K
D9999	Unspecified adjunctive procedure, by report	<1%	31	$27K
80053	Comprehensive metabolic panel	<1%	2,712	$24K
36415	Collection of venous blood by venipuncture	<1%	4,751	$24K
96361	Intravenous infusion, hydration; each additional hour	<1%	432	$21K
62323		<1%	46	$20K
84484		<1%	1,710	$19K
80048	Basic metabolic panel (calcium, ionized)	<1%	1,774	$13K
71046	Radiologic examination, chest; 2 views	<1%	780	$12K
95811		<1%	25	$10K
81003		<1%	2,032	$8K
94060		<1%	197	$7K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	879	$6K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	25	$5K
87086	Culture, bacterial; quantitative colony count, urine	<1%	588	$4K
82550		<1%	625	$4K
76000		<1%	173	$4K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	94	$3K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	94	$3K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	29	$2K
70450	Computed tomography, head or brain; without contrast material	<1%	39	$2K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	37	$2K
83690		<1%	296	$2K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	34	$2K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	126	$1K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	14	$1K
97597		<1%	116	$1K
83735		<1%	176	$1K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	235	$868.88
99213	Doctor's office visit, returning patient (routine)	<1%	14	$546.03
82962		<1%	187	$543.12
94729		<1%	13	$479.05
94726		<1%	13	$417.80
73564		<1%	12	$363.81
87210		<1%	56	$269.58
87077		<1%	29	$208.51
71250		<1%	12	$190.85
82948		<1%	44	$167.15
86780		<1%	24	$153.14
87807		<1%	13	$151.45
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	234	$86.04
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	29	$52.58
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	667	$36.90
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	93	$6.98
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	0%	140	$0.00
J1200	Injection, diphenhydramine hcl, up to 50 mg	0%	76	$0.00
J1644	Injection, heparin sodium, per 1000 units	0%	42	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	82	$0.00
J1885	Injection, ketorolac tromethamine, per 15 mg	0%	124	$0.00
94761		0%	68	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	26	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDUNAWAY, HEATHER (BUSINESS OFFICE MANAGER)